找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Antiepileptic Drugs; Pharmacology and The Mervyn J. Eadie,Frank J. E. Vajda Book 1999 Springer-Verlag Berlin Heidelberg 1999 catecholamines

[復(fù)制鏈接]
樓主: Abridge
51#
發(fā)表于 2025-3-30 09:52:01 | 只看該作者
52#
發(fā)表于 2025-3-30 14:42:35 | 只看該作者
53#
發(fā)表于 2025-3-30 17:14:47 | 只看該作者
54#
發(fā)表于 2025-3-30 22:20:35 | 只看該作者
https://doi.org/10.1007/978-3-662-31601-6 predicted from its chemistry; rather they were discovered by routine screening of various 1,2-benzisoxazole derivatives. Its formula is C.H.N.O.S, and its molecular weight is 212. It has a p.. of 9.66, so that its water solubility is dependent on the pH. Below a pH of 8, it has a solubility of only
55#
發(fā)表于 2025-3-31 04:12:06 | 只看該作者
Antiepileptic Drugs978-3-642-60072-2Series ISSN 0171-2004 Series E-ISSN 1865-0325
56#
發(fā)表于 2025-3-31 06:12:52 | 只看該作者
Grundlagen der Eisenwerkstoffe,atment for partial seizures, whether or not they became secondarily generalized, and for primary generalized tonic-clonic seizures. The estimated patient exposure to the drug currently exceeds 50,000 patient years. Oxcarbazepine is under active investigation in the United States.
57#
發(fā)表于 2025-3-31 12:13:09 | 只看該作者
https://doi.org/10.1007/3-540-29793-6c, sedative and antiepileptic activity and received marketing approval in 1960 (. et al. 1960). Although effective, the drug was noted to have significant toxicity and chemists then turned to synthesizing structural analogues in the hope of finding compounds with enhanced pharmacological activity and reduced toxicity.
58#
發(fā)表于 2025-3-31 16:04:53 | 只看該作者
https://doi.org/10.1007/978-3-642-60072-2catecholamines; chemistry; clinical trial; cortex; drug; drug development; epilepsy; kinetics; neuropeptides
59#
發(fā)表于 2025-3-31 21:07:10 | 只看該作者
978-3-642-64244-9Springer-Verlag Berlin Heidelberg 1999
60#
發(fā)表于 2025-4-1 00:15:32 | 只看該作者
Mervyn J. Eadie,Frank J. E. VajdaIncludes supplementary material:
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-11 22:23
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
通道| 乌拉特中旗| 邮箱| 诸城市| 乐亭县| 峨眉山市| 金山区| 平南县| 神木县| 积石山| 遵化市| 册亨县| 自治县| 道孚县| 西华县| 金湖县| 鸡泽县| 昭平县| 桂阳县| 林西县| 玛沁县| 鄱阳县| 高雄县| 扶绥县| 东乌珠穆沁旗| 江华| 海安县| 日喀则市| 平陆县| 东安县| 华坪县| 甘谷县| 如东县| 将乐县| 开平市| 甘德县| 罗甸县| 托里县| 林西县| 府谷县| 珠海市|